These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 19617612)
1. Survival time of dogs with inflammatory mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy. Clemente M; De Andrés PJ; Peña L; Pérez-Alenza MD Vet Rec; 2009 Jul; 165(3):78-81. PubMed ID: 19617612 [TBL] [Abstract][Full Text] [Related]
2. Survival time of dogs with inflammatory mammary cancer. Ness M Vet Rec; 2009 Aug; 165(9):272; author reply 272. PubMed ID: 19717839 [No Abstract] [Full Text] [Related]
3. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy. Oblak ML; Boston SE; Higginson G; Patten SG; Monteith GJ; Woods JP Vet Surg; 2012 Apr; 41(3):430-5. PubMed ID: 23253085 [TBL] [Abstract][Full Text] [Related]
4. Survival in dogs with nasal adenocarcinoma: 64 cases (1981-1995). Henry CJ; Brewer WG; Tyler JW; Brawner WR; Henderson RA; Hankes GH; Royer N J Vet Intern Med; 1998; 12(6):436-9. PubMed ID: 9857336 [TBL] [Abstract][Full Text] [Related]
5. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity. Yen CC; Tung SL; Hsieh RK; Chiou TJ; Liu JH; Wang WS; Chen PM Jpn J Clin Oncol; 1997 Oct; 27(5):316-20. PubMed ID: 9390208 [TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy. Tran CM; Moore AS; Frimberger AE Vet Comp Oncol; 2016 Sep; 14(3):252-62. PubMed ID: 24735412 [TBL] [Abstract][Full Text] [Related]
7. The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma. Rossi F; Sabattini S; Vascellari M; Marconato L Vet Comp Oncol; 2018 Dec; 16(4):497-504. PubMed ID: 29806156 [TBL] [Abstract][Full Text] [Related]
8. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. Hillers KR; Lana SE; Fuller CR; LaRue SM J Am Anim Hosp Assoc; 2007; 43(4):187-92. PubMed ID: 17615398 [TBL] [Abstract][Full Text] [Related]
9. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. Poirier VJ; Forrest LJ; Adams WM; Vail DM J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049 [TBL] [Abstract][Full Text] [Related]
10. Survival time following hospital discharge in dogs with palliatively treated primary brain tumors. Rossmeisl JH; Jones JC; Zimmerman KL; Robertson JL J Am Vet Med Assoc; 2013 Jan; 242(2):193-8. PubMed ID: 23276095 [TBL] [Abstract][Full Text] [Related]
11. Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea. Kim HK; Lee SH; Kim YJ; Park SE; Lee HS; Lim SW; Cho JH; Kim JY; Ahn JS; Im YH; Yu JH; Park YH BMC Cancer; 2019 Jan; 19(1):84. PubMed ID: 30654765 [TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. Bezwoda WR; Seymour L; Dansey RD J Clin Oncol; 1995 Oct; 13(10):2483-9. PubMed ID: 7595697 [TBL] [Abstract][Full Text] [Related]
13. Outcome and prognostic factors in medically treated canine prostatic carcinomas: A multi-institutional study. Ravicini S; Baines SJ; Taylor A; Amores-Fuster I; Mason SL; Treggiari E Vet Comp Oncol; 2018 Dec; 16(4):450-458. PubMed ID: 29806232 [TBL] [Abstract][Full Text] [Related]
14. Metronomic administration of lomustine following palliative radiation therapy for appendicular osteosarcoma in dogs. Duffy ME; Anderson CL; Choy K; Fidel JL Can Vet J; 2018 Feb; 59(2):136-142. PubMed ID: 29386671 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate. Alonso-Miguel D; Valdivia G; García-San José P; Alonso-Diez Á; Clares I; Portero M; Peña L; Pérez-Alenza MD Vet Comp Oncol; 2022 Mar; 20(1):179-188. PubMed ID: 34390295 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma. Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577 [TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma. Finotello R; Henriques J; Sabattini S; Stefanello D; Felisberto R; Pizzoni S; Ferrari R; Marconato L Vet Comp Oncol; 2017 Jun; 15(2):493-503. PubMed ID: 26792231 [TBL] [Abstract][Full Text] [Related]
18. Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study. Kantoff PW; Halabi S; Conaway M; Picus J; Kirshner J; Hars V; Trump D; Winer EP; Vogelzang NJ J Clin Oncol; 1999 Aug; 17(8):2506-13. PubMed ID: 10561316 [TBL] [Abstract][Full Text] [Related]
19. Outcome following treatment of vertebral tumors in 20 dogs (1986-1995). Dernell WS; Van Vechten BJ; Straw RC; LaRue SM; Powers BE; Withrow SJ J Am Anim Hosp Assoc; 2000; 36(3):245-51. PubMed ID: 10825097 [TBL] [Abstract][Full Text] [Related]
20. Mammary carcinoma: Comparative oncology between small animals and humans-New therapeutic tools. Frénel JS; Nguyen F Reprod Domest Anim; 2023 Sep; 58 Suppl 2():102-108. PubMed ID: 37312625 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]